liraglutide for Obesity
Study Summary
This trial will study the effect of a drug called Liraglutide on areas of the brain that control appetite and food intake.
Eligibility Criteria
Inclusion Criteria
You will be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2014 Phase 4 trial • 368 Patients • NCT02008682Awards & Highlights
Trial Design
Find a site
Who is running the clinical trial?
Media Library
Frequently Asked Questions
Is there still capacity available to participants in this experiment?
"This investigation is no longer seeking participants, as the trial was first posted on November 1st 2016 and last updated on July 18th 2022. However, clinicaltrials.gov lists 992 other studies that are currently open for enrolment."
Are there any potential risks to utilizing liraglutide as a treatment?
"The safety of liraglutide attained a score of 3 on our evaluation metrics, as it is currently in its fourth phase and has already been approved."
What qualifications must one meet in order to take part in this medical research?
"This research initiative is seeking 28 individuals with obesity to participate. To qualify, applicants must have a BMI of more than 30 kg/m2 or greater than 27kg/m2 and any accompanying comorbidities (such as insulin resistance, hypertension, dyslipidemia, cardiovascular disease, stroke, sleep apnea, gallbladder disease hyperuricemia and gout). The ages accepted range from 18-100 years old."
Up to how many participants can join this clinical experiment?
"At present, this trial is not enrolling new patients. Initially posted on November 1st 2016 and last updated on July 18th 2022, it does not currently offer any opportunities for participation. However, if you are searching for other clinical trials to consider joining , there are 957 studies related to obesity that have open positions as well as 35 trails utilizing liraglutide which are actively recruiting participants."
Is the demographic for this research project limited to participants under 35 years of age?
"According to the qualifications for this trial, those aged between 18 and 100 are eligible to apply. Additionally, there exist 208 clinical trials specifically tailored towards minors and 621 catered towards elderly patients."
What therapeutic applications has liraglutide been found to be useful for?
"liraglutide is widely prescribed to treat physical activity, as well as inadequate control on monotherapy, cardiovascular risk reduction, and coronary vascular disease."